Overview
- Product nameAnti-Cyclin A antibody [C160]See all Cyclin A primary antibodies ...
- DescriptionMouse monoclonal [C160] to Cyclin A
- Tested applicationsWB more details
- Species reactivityReacts with: Human
- Immunogen
This antibody was raised against the full-length protein corresponding to human Cyclin A.
- Positive controlK-562 nuclear extract.
Properties
- FormLiquid
- Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
- Storage bufferPreservative: 0.1% Sodium Azide, 0.01% Thimerosal (merthiolate)
Constituents: 0.2% Gelatin, PBS - PurityTissue culture supernatant
- Clonality Monoclonal
- Clone numberC160
- IsotypeIgG1
- Research Areas
Applications
Our Abpromise guarantee covers the use of ab11925 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| WB |
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Target
- FunctionEssential for the control of the cell cycle at the G1/S (start) and the G2/M (mitosis) transitions.
- Sequence similaritiesBelongs to the cyclin family. Cyclin AB subfamily.
- Developmental stageAccumulates steadily during G2 and is abruptly destroyed at mitosis.
- Cellular localizationNucleus. Cytoplasm. Cytoplasmic when associated with SCAPER.
-
Database links
- Entrez Gene: 890 Human
- Omim: 123835 Human
- SwissProt: P20248 Human
- Unigene: 58974 Human
Target information above from: UniProt accession
P20248
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
-
Alternative names
- CCN1 antibodyCCNA antibodyCCNA antibody
- CCNA2 antibodyCCNA2_HUMAN antibodyCyclin A2 antibodyCyclin A2 antibodyCyclin A2 antibodyCyclin-A antibodyCyclin-A2 antibody
see all
References for Anti-Cyclin A antibody [C160] (ab11925)
ab11925 has not yet been referenced specifically in any publications.